ARRY : Summary for Array BioPharma Inc. - Yahoo Finance

U.S. Markets closed

Array BioPharma Inc. (ARRY)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
10.88-0.49 (-4.31%)
At close: 4:00PM EST
People also watch
EXELARQLCLDXARIARIGL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close11.37
Open11.46
Bid10.85 x 1000
Ask11.29 x 200
Day's Range10.83 - 11.53
52 Week Range2.44 - 13.40
Volume3,105,339
Avg. Volume4,132,690
Market Cap1.84B
Beta1.64
PE Ratio (TTM)-16.39
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Want to Get In on Biotech? Check Out These 3 Stocks
    Motley Fool7 days ago

    Want to Get In on Biotech? Check Out These 3 Stocks

    If you're new to biotech investing, these are three companies you need to know.

  • Capital Cube7 days ago

    ETFs with exposure to Array BioPharma, Inc. : February 14, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Array BioPharma, Inc. Here are 5 ETFs with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q2, 2017 By the Numbers : February 13, 2017
    Capital Cube9 days ago

    Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q2, 2017 By the Numbers : February 13, 2017

    Categories: Yahoo Finance Get free summary analysis Array BioPharma, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Array BioPharma, Inc. – Amgen Inc., Celgene Corporation, Astrazeneca PLC Sponsored ADR, Eli Lilly and Company and Novartis AG Sponsored ADR (AMGN-US, CELG-US, AZN-US, LLY-US and NVS-US) that ... Read more (Read more...)